RE:RE:RE:With the Recent FDA Breakthrough Designation MM,
I can't be bothered to apply an EBIDITA multiple to the 55 mil annual opportunity in Canada but you may want to for fun.
As Far as PMX FDA approval goes the CEO called it "near term" and seemed giddy in doing so.
Given their 3 of 4 PMA modules into the FDA, have a 100% safety profile across Europe and Japan, are using 176 patients from the previous trial, have an FDA BTD designation and the trial is greatly "exceeding expectations" I expect an approval and a Baxter takeout with 14 trading days.